GeneReach Biotechnology Past Performance
How has GeneReach Biotechnology performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4171 has high quality earnings.
Growing Profit Margin: 4171's current net profit margins (38.1%) are higher than last year (37.6%).
Past Earnings Growth Analysis
Earnings Trend: 4171 has become profitable over the past 5 years, growing earnings by 60.2% per year.
Accelerating Growth: 4171's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4171 had negative earnings growth (-16.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (28.2%).
Return on Equity
High ROE: 4171's Return on Equity (28.4%) is considered high.